Protocol failure detection: The conflation of acute respiratory distress syndrome, SARS-CoV-2 pneumonia and respiratory dysfunction

被引:0
|
作者
Lynn, Lawrence A. [1 ]
Wheeler, Emily [4 ]
Woda, Russel [2 ]
Levitov, Alexander B. [6 ]
Stawicki, Stanislaw P. [5 ]
Bahner, David P. [3 ]
机构
[1] OhioHlth Doctors Hosp, Dept Pulmonol, Columbus, OH USA
[2] Ohio State Univ, Wexner Med Ctr, Dept Anesthesiol, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Emergency Med, Columbus, OH 43210 USA
[4] Florida State Univ, Sarasota Mem Hosp, Dept Emergency Med, Sarasota, FL USA
[5] St Lukes Univ Hlth Network, Dept Res & Innovat, Bethlehem, PA USA
[6] Eastern Virginia Med Sch, Dept Pulm & Crit Care Med, Norfolk, VA 23501 USA
关键词
Acute respiratory distress syndrome; COVID-19; protocol failure; SARS-CoV-2; SUBPHENOTYPES; ARDS; VENTILATION; HYPOXIA; TIME;
D O I
10.4103/jets.jets_75_21
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
In medicine, protocols are applied to assure the provision of the treatment with the greatest probability of success. However, the development of protocols is based on the determination of the best intervention for the group. If the group is heterogeneous, there will always be a subset of patients for which the protocol will fail. Furthermore, over time, heterogeneity of the group may not be stable, so the percentage of patients for which a given protocol may fail may change depending on the dynamic patient mix in the group. This was thrown into stark focus during the severe acute respiratory syndrome-2 coronavirus (SARS-CoV-2) pandemic. When a COVID-19 patient presented meeting SIRS or the Berlin Criteria, these patients met the criteria for entry into the sepsis protocol and/or acute respiratory distress syndrome (ARDS) protocol, respectively and were treated accordingly. This was perceived to be the correct response because these patients met the criteria for the "group" definitions of sepsis and/or ARDS. However, the application of these protocols to patients with SARS-CoV-2 infection had never been studied. Initially, poor outcomes were blamed on protocol noncompliance or some unknown patient factor. This initial perception is not surprising as these protocols are standards and were perceived as comprising the best possible evidence-based care. While the academic response to the pandemic was robust, recognition that existing protocols were failing might have been detected sooner if protocol failure detection had been integrated with the protocols themselves. In this review, we propose that, while protocols are necessary to ensure that minimum standards of care are met, protocols need an additional feature, integrated protocol failure detection, which provides an output responsive to protocol failure in real time so other treatment options can be considered and research efforts rapidly focused.
引用
收藏
页码:227 / 231
页数:5
相关论文
共 50 条
  • [1] Iatrogenic tracheal rupture in a patient with acute respiratory distress syndrome due to SARS-CoV-2 pneumonia
    Martinez, P. Redondo
    Herreros, N. Gijon
    Garcia, D. R. Delgado
    Caballero, E. Quilez
    Munoz, M. C. Porras
    Manzano, S. Garcia Del Valle y
    REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2021, 68 (10): : 597 - 601
  • [2] Ventilator-associated pneumonia among SARS-CoV-2 acute respiratory distress syndrome patients
    Fumagalli, Jacopo
    Panigada, Mauro
    Klompas, Michael
    Berra, Lorenzo
    CURRENT OPINION IN CRITICAL CARE, 2022, 28 (01) : 74 - 82
  • [3] Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome—with a preliminary reference to SARS-CoV-2 pneumonia
    Walter Gottlieb Land
    Genes & Immunity, 2021, 22 : 141 - 160
  • [4] EVALUATION OF CORTICOSTEROID DURATION ON SARS-COV-2 ACUTE RESPIRATORY DISTRESS SYNDROME
    Grant, Ryan
    Crotty, Matthew
    Rahmanzadeh, Kristen
    Acharya, Priyanka
    Krishnamurthy, Raghu
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 207 - 207
  • [5] Acute respiratory distress syndrome secondary to SARS-CoV-2 infection in an infant
    Lahfaoui, M.
    Azizi, M.
    Elbakkaoui, M.
    El Amrani, R.
    Kamaoui, I.
    Benhaddou, H.
    REVUE DES MALADIES RESPIRATOIRES, 2020, 37 (06) : 502 - 504
  • [6] Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2)
    Maveddat, Ashley
    Mallah, Haneen
    Rao, Sanjana
    Ali, Kiran
    Sherali, Samir
    Nugent, Kenneth
    INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2020, 11 (04): : 157 - 178
  • [7] Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia
    Land, Walter Gottlieb
    GENES AND IMMUNITY, 2021, 22 (03) : 141 - 160
  • [8] Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
    Andreas Neubauer
    Thomas Wiesmann
    Claus F. Vogelmeier
    Elisabeth Mack
    Chrysanthi Skevaki
    Christine Gaik
    Christian Keller
    Jens Figiel
    Kristina Sohlbach
    Caroline Rolfes
    Harald Renz
    Hinnerk Wulf
    Andreas Burchert
    Leukemia, 2020, 34 : 2276 - 2278
  • [9] Efficacy of Almitrine in the Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome
    Barthelemy, Romain
    Blot, Pierre-Louis
    Tiepolo, Ambre
    Gall, Arthur Le
    Mayeur, Claire
    Gaugain, Samuel
    Morisson, Louis
    Gayat, Etienne
    Mebazaa, Alexandre
    Chousterman, Benjamin Glenn
    CHEST, 2020, 158 (05) : 2003 - 2006
  • [10] Ventilatory Management of Patients with Acute Respiratory Distress Syndrome Due to SARS-CoV-2
    Jacquier, Marine
    Labruyere, Marie
    Ecarnot, Fiona
    Roudaut, Jean-Baptiste
    Andreu, Pascal
    Voizeux, Pierre
    Save, Quentin
    Pedri, Romain
    Rigaud, Jean-Philippe
    Quenot, Jean-Pierre
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (24)